Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome.

Ying Chen,Tingting Niu, Ting Chen,Yue Wu,Duobing Zou,Cong Shi,Ying Wu,Zhaoyi Zhang,Ningning Wu,Yi Zhang,Xiao Yan,Lixia Sheng,Dingfeng Lv,Guifang Ouyang,Xueqin Chen,Qitian Mu

Frontiers in nutrition（2023）

引用 0|浏览37

暂无评分

摘要

The results indicate that decreased transthyretin could be an independent adverse prognostic factor in patients with MDS and may provide a supplement to IPSS-R and IPSS-M.

查看译文

关键词

IPSS-M,IPSS-R,myelodysplastic syndromes,prognosis,transthyretin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要